



Multiple Depressive Episodes and Plasma 
Postdexamethasone Cortisol Levels 
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Roger F. Haskett, and John F. Greden 
The hypothalamic-pituitary-adrenal (HPA) axis is dysregulated in many patients with 
major depressive disorder (Moo). To determine whether or not a past history of de- 
pressive episodes is associated with this dysregulation, we studied the relationships among 
number of past depressive episodes, number of previous hospitalizations for depression, 
and number of years since first depressive episode and biological markers of depression 
(postdexamethasone plasma cortisol levels and dexamethasone suppressorlnonsuppressor 
status). No sign$cant relationships were detected. 
Introduction 
Many patients with major depressive disorder (MDD) develop hypothalamic- 
pituitary-adrenal (HPA) axis dysregulation during episodes of depression (Carroll et al. 
1981). This dysregulation in depressed individuals appears to exist at both the adrenal 
and pituitary levels, as reflected by abnormal postdexamethasone responses of plasma 
cortisol (Carroll et al. 1981; Charles et al. 1981; Brown et al. 1985) and proopiomelan- 
ocortin-derived peptides: P-endorphin (Matthews et al. 1982; 1986) and adrenocortico- 
trophic hormone (ACTH) (Kahn et al. 1982; Nasr et al. 1983b; Pfohl et al. 1985; Sherman 
and Pfohl 1985). The possible dysregulation of the hypothalamic hormone corticotrophin- 
releasing factor (CRP) in depression is also being explored (Chrousos et al. 1983; Gold 
et al. 1984; Halsboer et al. 1985). 
Numerous factors have been shown to influence the apparent degree of HPA axis 
dysregulation in MDD. Age (Oxenkrug et al. 1983; Davis et al. 1984; Lewis et al. 1984), 
recent weight change (Keitner et al. 1985; Krishnan et al. 1985b), polarity (Zisook et al. 
1985), psychosis (Rudorfer et al. 1982), and severity of illness (Reus 1982; Nasr and 
Gibbons 1983; Nasr et al. 1983a; Sangal et al. 1984; Krishnan et al. 1985a) have been 
found to affect postdexamethasone cortisol responses. In addition, antidepressant with- 
drawal (Dilsaver and Greden 1985), alcoholism (Kroll et al. 1983), dose of dexamethasone 
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(Brown et al. 1983), timing and frequency of plasma samples (Goldberg 1980), and 
cortisol assay characteristics (Demers and Derek 1977; Meltzer and Fang 1983) can 
influence Dexamethasone Suppression Test (DST) results. 
In view of the pervasiveness of these changes, it would be of great interest to determine 
whether or not the HPA axis dysregulation seen in MDD is modulated by the past history 
of depressive episodes. Does the HPA axis return completely to its premorbid state 
following resolution of each depressive episode, or does some degree of dysregulation 
persist and interact with changes occurring during subsequent episodes? Surprisingly few 
studies have addressed this issue, and findings to date have been contradictory. Lenox 
et al. ( 1985) studied 20 depressed patients and noted a trend for DST nonsuppressors to 
report more prior depressive episodes than suppressors. They also observed that more 
years had elapsed since the first episode of MDD (i.e., age at index episode minus age 
of first episode) in patients who were DST nonsuppressors than the suppressors in their 
population. However, other investigators (Brown and Qualls 1982; Grunhaus et al. 1983; 
Yerevanian et al. 1984) have reported that DST suppression status did not change between 
hospitalizations for sequential depressive episodes in most of the MDD patients they 
studied, suggesting that number of depressive episodes does not affect the degree of HPA 
axis dysregulation in MDD. In an attempt to clarify these issues, we investigated a large 
population of patients with MDD for whom these data were available; to maximize the 
descriptive power of our data, we explored this problem by several different methods. 
Methods 
Patients 
Eighty-one patients in the Clinical Studies Unit (CSU) for Affective Disorders of the 
Department of Psychiatry at the University of Michigan from 1980 to 1985 were identified. 
All patients admitted to the CSU undergo a comprehensive diagnostic evaluation, in- 
cluding several clinical interviews by psychiatrists, a structured interview by a trained 
research staff member using the Schedule for Affective Disorders and Schizophrenia 
(SADS) (Spitzer and Endicott 1975), and a detailed family history and social assessment 
by a social worker, as well as a thorough physical and laboratory evaluation. Diagnosis 
is made by consensual agreement of the clinicians involved in gathering the above in- 
formation, using Research Diagnostic Criteria (RDC) (Spitzer et al. 1977). 
Patients included in the present study (1) met RDC (Spitzer et al. 1977) for major 
depressive disorder (MDD); (2) did not meet psychotic subtype; (3) had 17-item Hamilton 
Rating Scale for Depression (HRSD) (Hamilton 1960) scores of at least 16; (4) completed 
a Dexamethasone Suppression Test (DST) following a medication-free period of 2 weeks; 
(5) had no identifiable technical exclusions known to invalidate the DST (Carroll et al. 
198 1); and (6) gave written informed consent to participate in these research activities. 
Laboratory Procedures 
Each patient received 1 mg of dexamethasone at 11:30 PM on the night prior to study, 
and blood was collected the following day for cortisol determination. Samples were 
typically obtained at 8:OO AM, 4:00 PM, and 11:OO PM, although fewer than all three 
samples were collected for most patients. Plasma cortisol concentration was determined 
by a modification of Murphy’s (1967) competitive protein-binding technique. 
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Data Acquisition 
Three parameters were available in our database to express multiplicity of depressive 
episodes: (1) number of previous lifetime major depressive episodes (“depressive epi- 
sodes” or DE), (2) number of previous lifetime hospit~izations for MDD (“depressive 
hospitalizations” or DH), and (3) number of years since the patient’s first depressive 
episode (“years depressed” or YD). Empirically, one might expect DE and DH to be 
highly related to each other; examination revealed, however, that although the two are 
significantly correlated, only 48% of the variance is attributable to this relationship. 
Accordingly, we included DH as a separate parameter of multiplici~ of depressive 
episodes. The data DE, DH, and YD are routinely obtained at the time of hospi~lization 
from interviews with the patient, family members, and current and previous therapists; 
this information is entered into our database at the time it is obtained. As any analysis 
depends on the accuracy of these data, every effort is made at the time of hospitalization 
to corroborate this information by obtaining the actual records of as many past psychiatric 
hospitalizations of each patient as possible. Additionally, other variables, such as age, 
degree of recent weight change, and HRSD score at the time of the DST, are entered 
into our dataset and were available for this study. 
Data Analysis 
As the direction of causality is not well understood, the relationship between these three 
parameters (DE, DH, and YD) and postdexamethasone cortisol values was studied by 
three different methods. All results are expressed t SEM, unless otherwise specified. 
Method 1. For each multiplicity parameter, the patient population was divided into 
tertiles of approximately equal size, ~presenting mild, moderate, and severe patterns. 
For DE, 0, 1-3, and 4-8 previous depressive episodes characterized the respective groups; 
for DH, 0, 1-2, and 3-8 previous hospitalizations for depression; and for YD, O-IO, 
10-20, and >20 years since first depressive episode. Mean age, HRSD score, degree of 
recent weight change, and logarithmically transformed postdexamethasone plasma cortisol 
values at the three sampling times were calculated for each group for each parameter. 
Between-group differences were tested by one-way Analysis of Variance (ANOVA). 
Method 2. Correlation coefficients were calculated among DE, DH, and YD, and 
logarithmically transformed postdexamethasone co&o1 values at 8:00 AM, 4:00 PM, and 
11:00 PM, age, recent weight loss, and HRSD score. Pearson’s product-moment corre- 
lation coefficient was calculated for the tests of association between YD and the other 
listed variables. As DE and DH are not continuously dis~buted variables, Kendall’s Tau- 
B coefficient of rank correlation, corrected for tied ranks (Conover 197 1; Gibbons 1971) 
was employed for tests of association between DE and DH and the other variables. 
Method 3. For this method, we reversed dependent and independent variables to study 
this phenomenon in a more ~aditional manner (Carroll et al. 1981). Patients were defined 
as DST suppressors or nonsupp~sso~: nonsuppression was defined as having a maximum 
postdexamethasone cortisol value of >5 pg/dl. We compared mean age, degree of weight 
change, HRSD scores, and the three multiplicity parameters for suppressors and non- 
suppressors; comparison was by one-way ANOVA. 
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Results 
Method I 
The results of studying postdexamethasone cortisol levels as a function of degree of 
number of DE is shown in Figure 1. Although there was a trend toward higher cortisol 
levels at 8:CKJ AM and 490 PM as a function of number of previous depressive episodes, 
for none of the three time points were the across-group differences significant. There 
were, however, significant across-group differences for degree of recent weight change. 
Age and HRSD scores were not significantly different among the three groups. 
A similar analysis of cortisol levels as a function of degree of number of DH is 
summarized in Figure 2. None of the between-group differences was significant for any 
of the three cortisol sampling times. Age and HRSD scores did show trends toward being 
higher as a function of DH. Recent weight loss was not significantly related to DH. 
Figure 3 shows the results of examining cortisol levels as a function of number of 
YD. Again, none of the across-group differences attained statistical significance. As 
might be expected, however, age was significantly related to this parameter. HRSD scores 
and recent weight change were not significantly different among the groups. 
Method 2 
The results of correlating the multiplicity parameters DE, DH, and YD with cortisol 
values are shown in Table 1. None of the parameters was significantly correlated with 
Figure 1. Postdexamethasone cortisol levels as a function of number of previous depressive episodes 
at 8:oO AM, 4:oO PM, and 11:OO PM. The between-group differences are not significant for any of 
the three time points. 
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Figure 2. Postdexamethasone cortisol levels as a function of number of past hospitalizations for 
depression at 890 AM, 400 PM, and 11 :@I PM. The between-group differences are not significant 
for any of the three time points. 
any of the three postdexamethasone cortisol samples. Significant correlations, however, 
existed between DH and age and YD and both age and HRSD score. 
Method 3 
Table 2 summarizes the results of comparing the multiplicity parameters and other vari- 
ables for DST suppressors and nonsuppressors. None of the three multiplicity parameters 
was significantly different among these groups. DST nonsuppressors, however, were 
significantly older than DST suppressors. 
Discussion 
These results indicate that past history of depressive experience does not affect the degree 
of HPA axis dysregulation seen in MDD as indicated by postdexamethasone cortisol 
levels. We initially designed this study to examine the effects of mild, moderate, and 
severe degrees of the three multiplicity parameters on postdexamethasone cortisol levels. 
Due to the negative findings, we reexamined the data by using correlation coefficients 
to insure that the stratification procedure had not biased the results. Finally, we studied 
the problem using the more conventional method (Carroll et al. 1981) of identifying 
patients as DST suppressors and nonsuppressors and comparing the three multiplicity 
parameters for each group. Regardless of the method employed, we found no significant 
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Figure 3. Postdexamethasone cortisol levels as a function of number of years since first depressive 
episode at 890 AM, 4:oO PM, and 11 :(I0 PM. The between-group differences are not significant for 
any of the three time points. 
relationships between postdexamethasone cortisol levels and any of the three multiplicity 
parameters (number of previous depressive episodes, number of previous hospitalizations 
for depression, and number of years since first depressive episode). 
The 81 patients we studied in this investigation represent the largest group of subjects 
yet employed to examine this phenomenon. Yerevanian et al. (1984) found that DST 
suppressor/nonsuppressor status was unchanged upon readmission to the hospital for 
recurrent depressive episodes in 11 of 12 patients studied, which is in agreement with 
our findings. Similarly, Grunhaus et al. (1983) found that DST suppressor/nonsuppressor 
status was unchanged in 7 of 10 patients upon readmission for recurrent MDD. Brown 
and Qualls (1982) studied 11 patients and found that the 6 patients who were DST 
suppressors during the index episode of MDD remained suppressors in subsequent epi- 
sodes, but several of 5 initial nonsuppressors became suppressors. In a study of 20 patients 
with MDD, however, Lenox et al. (1985) found that DST suppressors had a significantly 
shorter length of illness (YD in the present study) than did nonsuppressors. The nonsup- 
pressers were older than the suppressors in their study, however, and an examination of 
the data they presented suggests that if age were introduced as a covariate in their analysis, 
this apparent trend might fail to reach statistical significance. In addition, they found no 
difference in number of previous depressive episodes between DST suppressors and 
nonsuppressors. The findings of the present study and of the previous studies, taken 
together, suggest that the magnitude of dysregulation of the HPA axis is not a function 
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Table 1. Coefficients of Correlation of Indices of Multiplicity of Depressive Episodes with 
Postdexarnetbasone Plasma Cortisol Levels and Clinically Relevant Variables” 
Variable 





890 a4 cordsoP 
4:00 PM cords01 
11:OO PM cortisol 
Age 
HRSD score 
Recent weight change 
+0.06 +0.08 - 0.03 
+0.03 +0.06 +0.03 
-0.01 +0.15 -0.10 
+0.09 +0.1y + 0.46d 
+0.15 +0.15 +0.23’ 
-0.15 -0.13 +0.05 
“Values reported are Pearson product-moment correlation coefficients for the continuously distributed variable (years since 
tirst depressive episode) and Kendall’s Tau-B coefficients of rank comlation for the noncontinuously distributed variables (past 
depressive episodes and hospitalizations). 
bAll cortisol values were logarithmically transformed prior to analysis. 
‘p < 0.05. 
“p < 0.01. 
of the number of previous depressive episodes; the axis does not “know” if the patient 
has been depressed only once or a dozen times, responding similarly during each de- 
pressive episode. 
The neuroendocrinology of depression is complex and incompletely understood. The 
hypercortisolemia (Carpenter and Bunney 1971; Carroll et al. 1976, 1981) and DST 
abnormalities seen at both the adrenal (Carroll et al. 1981; Charles et al. 1981; Brown 
et al. 1985) and pituitary (Kahn et al. 1982; Matthews et al. 1982, 1986; Nasr et al. 
1983b; Pfohl et al. 1985; Sherman and Pfohl 1985) levels are presumably related to 
limbic neurotransmitter disorganization, resulting in altered hypothalamic CRF secretion. 
Interestingly, however, depressed patients appear to be hyporesponsive to infusions of 
CRF, which is clearly different from the response of the pituitary in Cushing’s disease 
(Gold et al. 1984; Holsboer et al. 1984a, 1984b). Multiple levels of feedback regulation 
are operative in the HPA axis and complicate interpretation of this system. 
To definitively answer the question of whether or not the HPA axis dysregulation seen 
in MDD is modulated by the past history of the axis would require prespectively per- 
forming serial HPA measures on a large sample of patients between and during multiple 
Table 2. Multiplicity of Depressive Enisode Parameters as a Function of DST Suonression State 
Variable 
n 









Weight change (kg) 
DST suppressor 
51 
9.3 f 1.1 
2.2 f 0.3 
3.8 f 0.4 
37.8 + 2.0 
21.1 2 0.6 
-0.73 * 1.1 
DST nonsuppressor P 
30 
12.8 r 1.7 NS 
2.7 it 0.4 NS 
3.7 r 0.5 NS 
47.5 2 3.0 0.006 
22.6 IT 0.9 NS 
-3.3 2 1.3 NS 
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depressive episodes. Several investigators (Carroll et al. 1976; Greden et al. 1983) have 
followed depressed DST nonsuppressors through recovery from single episodes and have 
noted that many become DST suppressors once patients are euthymic. It may be, of 
course, that higher levels of the HPA axis (i.e., pituitary and hypothalamic) are dysre- 
gulated as a function of number of previous depressive episodes and that feedback mech- 
anisms are able to maintain cortisol homeostasis so that the adrenal response would not 
appear to be dependent on the number of past episodes. Following serial HPA measures 
(including plasma cortisol, ACTH, P-endorphin, and responsiveness to CRF infusion) in 
patients as they go through multiple depressive episodes has yet to be reported on a large 
scale, but would be the most reasonable strategy to thoroughly address this issue. 
The authors gratefully acknowledge Pamela Flegel and the CSU staff for their technical assistance, and Dr. C. 
Pomerleau for helpful suggestions regarding the manuscript. 
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